Skip to main content
SpringerLink
Log in

Orale antidiabetica naast insuline bij diabetes mellitus type 2

  • Redactie
  • Published:
Medisch-Farmaceutische Mededelingen

Samenvatting

Diabetes mellitus type 2 (DM 2) wordt veroorzaakt door een langzaam afnemende insulinesecretie door de β-cellen van de pancreas, terwijl ook perifere insulineresistentie een rol speelt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatuur

  • Garber AJ. Benefits of combination therapy of insulin and oral hypoglycemic agents. Arch Intern Med 2003;163:1781-2.

    Article  CAS  PubMed  Google Scholar 

  • Westphal SA, Palumbo PJ. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes. Arch Intern Med 2003;163:1783-5; discussion 1785.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. www.bsl.nl/shop/

    E. van der Does

Authors
  1. E. van der Does
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. C. M. Vingerhoeds
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

van der Does, E., Vingerhoeds, A.C.M. Orale antidiabetica naast insuline bij diabetes mellitus type 2. MFAM 42, 90–91 (2004). https://doi.org/10.1007/BF03058353

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03058353

Search

Navigation